CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Nasopharyngeal swab and main laboratoryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug1959 Q16 testing Wiki 1.00
drug1664 Observation of patients with known, suspected, or at risk for COVID-19 infection Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 COVID-19 in Vitro Diagnostic Near-patient Testing in Care Environments Using a Cluster Randomised Open-label Trial Design in an East London Care Home Population

The primary objective of the study is to determine whether, at 21 days, care homes that implemented near-patient daily testing have a lower rate of confirmed CoV-2 infections than care homes following the DHSC standard of care testing of symptomatic residents.

NCT04453553 COVID Diagnostic Test: Q16 testing Diagnostic Test: Nasopharyngeal swab and main laboratory

Primary Outcomes

Description: The cumulative number of confirmed cases of CoV-2 infection after 21 days, measured by PCR detection of CoV-2, within the care home residents, staff and visitors

Measure: CoV-2 Infection after 21 days

Time: 21 days

Secondary Outcomes

Description: The cumulative number of confirmed cases of CoV-2 infection after 14 days, measured by PCR detection of CoV-2, within the care home residents, staff and visitors.

Measure: CoV-2 Infection after 14 days

Time: 14 days

Description: The cumulative number of suspected or confirmed cases of CoV-2 infection after 14 days, within the care home residents, staff and visitors.

Measure: Cases of suspected or confirmed CoV-2 infection

Time: 14 days

Description: The cumulative number of confirmed COVID-19-related hospitalisations and deaths of care home residents, staff and visitors after 21 and 40 days.

Measure: Hospitalisation and death

Time: 21 days and 40 days


No related HPO nodes (Using clinical trials)